Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Verastem Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Axogen Inc. June 23, 202697.9%
-
Xeris Biopharma Holdings Inc. June 4, 202660.2%
-
Axogen Inc. June 18, 202583.7%
-
Verastem Inc. May 22, 202589.0%
-
Axogen Inc. June 4, 202483.1%
-
Axogen Inc. August 15, 202378.4%
-
Xeris Biopharma Holdings Inc. June 7, 202374.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 19, 2026 | Axogen Inc. | Option exercise | +14,150 | — | — |
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Open-market sale | −15,000 | $6.09 | $91,350 |
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Grant or award | +24,193 | — | — |
| May 21, 2026 | Verastem Inc. | Grant or award | +36,000 | — | — |
| May 7, 2026 | Axogen Inc. | Option exercise | +11,050 | $7.04 | $77,792 |
| May 7, 2026 | Axogen Inc. | Open-market sale | −11,050 | $43.26 | $478,023 |
| Dec 19, 2025 | Xeris Biopharma Holdings Inc. | Open-market sale | −135,400 | $7.22 | $977,588 |
| Dec 9, 2025 | Axogen Inc. | Option exercise | +8,545 | $6.30 | $53,834 |
| Dec 9, 2025 | Axogen Inc. | Open-market sale | −8,545 | $29.98 | $256,179 |
| Dec 9, 2025 | Axogen Inc. | Open-market sale | −13,141 | $29.98 | $393,967 |
| Dec 8, 2025 | Axogen Inc. | Open-market sale | −11,802 | $31.26 | $368,931 |
| Dec 8, 2025 | Axogen Inc. | Option exercise | +11,891 | $6.30 | $74,913 |
| Dec 8, 2025 | Axogen Inc. | Open-market sale | −11,891 | $31.22 | $371,237 |
| Aug 13, 2025 | Xeris Biopharma Holdings Inc. | Open-market sale | −107,500 | $7.32 | $786,900 |
| Jun 9, 2025 | Axogen Inc. | Open-market sale | −4,073 | $10.61 | $43,215 |
Questions about John Johnson
What boards is John Johnson on?
John Johnson sits on the boards of Axogen Inc., Verastem Inc. and Xeris Biopharma Holdings Inc.
How long has John Johnson served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.